Thanks for the clarification. Clinical centres in Canadian centres will also do a very good job. 
Regarding the ethics committees, they can be slow, especially if it's in an area the committee members know nothing about, which is likely with a BET inhibitor. So they will probably have farmed the application out to external reviewers with more delays. ABL has so much going for it, I can't believe they would turn it down.